BOSTON, March 19, 2026 (GLOBE NEWSWIRE)-- Damora Therapeutics, Inc. (formerly Galecto, Inc.) (“Damora” or the “Company”) (NASDAQ: DMRA), a biotechnology company working to fundamentally redefine care ...
-- DMR-001 on track for IND or CTA submission in mid-2026, with two clinical proof-of-concept datasets expected beginning mid-2027 -- -- Strong financial position with approximately $535 million in ...
Napa County’s winery code compliance program will come to an end in April, the Board of Supervisors unanimously decided Tuesday, March 10, after bringing nearly three dozen wineries into compliance ...
BOSTON, March 23, 2026 (GLOBE NEWSWIRE)-- Damora Therapeutics, Inc. (NASDAQ: DMRA), a biotechnology company working to fundamentally redefine care for patients with blood disorders, today announced ...
Investing.com -- Damora Therapeutics Inc (NASDAQ:DMRA) shares jumped 15.5% Monday following the announcement of Jennifer Jarrett as President and Chief Executive Officer, effective March 30, 2026.
-- Ms. Jarrett brings nearly three decades of executive leadership in biotech, tech and finance -- -- Biotech leaders Dr. Cameron Turtle and Mike Landsittel appointed to Board of Directors -- -- Peter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results